journal article·2014-01

Functionalization of magnetic nanoparticles with high-binding capacity for affinity separation of therapeutic proteins

Ingke-Christine Masthoff, Florian David, Christoph Wittmann, Georg Garnweitner

Journal of Nanoparticle Research· Volume 16· Issue 1
Publisher page

Abstract

Magnetic nanoparticles with immobilized metal ligands were prepared for the separation of antibody fragments. First, iron oxide nanoparticles were produced in a solvothermal synthesis using triethylene glycol as solvent and iron(III) acetylacetonate as organic precursor. Via functionalization of the particles with priorly reacted 3-glycidoxypropyltrimethoxysilane and N α,N α-bis(carboxymethyl)-l-lysine (NTA), and charging with Ni2+, magnetic affinity adsorbents were obtained. The particles were applied to separate a His-tagged antibody fragment from a heterogeneous protein mixture of a microbial cultivation supernatant. Binding properties and specificity for purification of the target product ABF D1.3 scFv were optimized regarding the GNTA concentration and were found superior as compared to commercially available systems. A molar ratio of 1:2 Fe2O3:GNTA was most beneficial for the specific purification of the antibody fragment.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Monoclonal and Polyclonal Antibodies Research · Protein purification and stability · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (35)

Show source-provided references
1. Anspach FB (1994) Silica-based metal chelate affinity sorbents. I. Preparation and characterization of iminodiacetic acid affinity sorbents prepared via different immobilization techniques. J Chromatogr A 672(1–2):35–49. doi: 10.1016/0021-9673(94)80592-X10.1016/0021-9673(94)80592-X ↗
2. Arias JL, Lopez-Viota M, Ruiz MA, Lopez-Viota J, Delgado AV (2007) Development of carbonyl iron/ethylcellulose core/shell nanoparticles for biomedical applications. Int J Pharm 339(12):237–245. doi: 10.1016/j.ijpharm.2007.02.02810.1016/j.ijpharm.2007.02.028 ↗
3. Bucak S, Jones DA, Laibinis PE, Hatton TA (2003) Protein separations using colloidal magnetic nanoparticles. Biotechnol Prog 19(2):477–484. doi: 10.1021/bp020085310.1021/bp0200853 ↗
4. Chang J, Kang K, Choi J, Jeong Y (2008) High efficiency protein separation with organosilane assembled silica coated magnetic nanoparticles. Superlattices Microstruct 44(4–5):442–448. doi: 10.1016/j.spmi.2007.12.00610.1016/j.spmi.2007.12.006 ↗
5. Cristancho CAM, David F, Franco-Lara E, Seidel-Morgenstern A (2013) Discontinuous and continuous purification of single-chain antibody fragments using immobilized metal ion affinity chromatography. J Biotechnol 163(2):233–242. doi: 10.1016/j.jbiotec.2012.08.02210.1016/j.jbiotec.2012.08.022 ↗
6. Csetneki I, Faix MK, Szilagyi A, Kovacs AL, Nemeth Z, Zrinyi M (2004) Preparation of magnetic polystyrene latex via the miniemulsion polymerization technique. J Polym Sci A Polym Chem 42(19):4802–4808. doi: 10.1002/pola.2030010.1002/pola.20300 ↗
7. David F, Steinwand M, Hust M, Bohle K, Ross A, Dübel S, Franco-Lara E (2011) Antibody production in Bacillus megaterium: strategies and physiological implications of scaling from microtiter plates to industrial bioreactors. Biotechnol J 6(12):1516–1531. doi: 10.1002/biot.20100041710.1002/biot.201000417 ↗
8. De Faria DLA, Venancio Silva S, De Oliveira MT (1997) Raman microspectroscopy of some iron oxides and oxyhydroxides. J Raman Spectrosc 28(11):873–878. doi:10.1002/(SICI)1097-4555(199711)28:11<873::AID-JRS177>3.0.CO;2-B10.1002/(SICI)1097-4555(199711)28:11<873::AID-JRS177>3.0.CO;2-B ↗
9. Duguet E, Vasseur S, Mornet S, Devoisselle JM (2006) Magnetic nanoparticles and their applications in medicine. Nanomedicine 1(2):157–168. doi: 10.2217/17435889.1.2.15710.2217/17435889.1.2.157 ↗
10. Durdureanu-Angheluta A, Dascalu A, Fifere A, Coroaba A, Pricop L, Chiriac H, Tura V, Pinteala M, Simionescu BC (2012) Progress in the synthesis and characterization of magnetite nanoparticles with amino groups on the surface. J Magn Magn Mater 324(9):1679–1689. doi: 10.1016/j.jmmm.2011.11.06210.1016/j.jmmm.2011.11.062 ↗
11. Faraji M, Yamini Y, Rezaee M (2010) Magnetic nanoparticles: synthesis, stabilization, functionalization, characterization, and applications. J Iran Chem Soc 7(1):1–37. doi: 10.1007/BF0324585610.1007/BF03245856 ↗
12. Frenzel A, Fröde D, Meyer T, Schirrmann T, Hust M (2012) Generating recombinant antibodies for research, diagnostics and therapy using phage display. Curr Biotechnol 1:31–41. doi: 10.2174/221155011120101003310.2174/2211550111201010033 ↗
13. Ghosh Chaudhuri R, Paria S (2011) Core/shell nanoparticles: classes, properties, synthesis mechanisms, characterization, and applications. Chem Rev 112(4):2373–2433. doi: 10.1021/cr100449n10.1021/cr100449n ↗
14. Grabs IM, Bradtmöller C, Menzel D, Garnweitner G. (2012) Formation mechanisms of iron oxide nanoparticles in different nonaqueous media. Cryst Growth Des 12(3):1469–1475. doi: 10.1021/cg201563h10.1021/cg201563h ↗
15. Grosvenor AP, Kobe BA, Biesinger MC, McIntyre NS (2004) Investigation of multiplet splitting of Fe2p XPS spectra and bonding in iron compounds. Surf Interface Anal 36(12):1564–1574. doi: 10.1002/sia.198410.1002/sia.1984 ↗
16. Gu H, Xu K, Xu C, Xu B (2006) Biofunctional magnetic nanoparticles for protein separation and pathogen detection. Chem Commun 9:941–949. doi: 10.1039/B514130C10.1039/b514130c ↗
17. Gupta AK, Gupta M (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26(18):3995–4021. doi: 10.1016/j.biomaterials.2004.10.01210.1016/j.biomaterials.2004.10.012 ↗
18. Hainfeld JF, Liu W, Halsey CMR, Freimuth P, Powell RD (1999) Ni-NTA gold clusters target His-tagged proteins. J Struct Biol 127(2):185–198. doi: 10.1006/jsbi.1999.414910.1006/jsbi.1999.4149 ↗
19. Heyd M, Franzreb M, Berensmeier S (2011) Continuous rhamnolipid production with integrated product removal by foam fractionation and magnetic separation of immobilized Pseudomonas aeruginosa. Biotechnol Prog 27(3):706–716. doi: 10.1002/btpr.60710.1002/btpr.607 ↗
20. Käppler T, Cerff M, Ottow K, Hobley T, Posten C (2009) In situ magnetic separation for extracellular protein production. Biotechnol Bioeng 102(2):535–545. doi: 10.1002/bit.2206410.1002/bit.22064 ↗
21. Khurshid H, Kim SH, Bonder MJ, Colak L, Ali B, Shah SI, Kiick KL, Hadjipanayis GC (2009) Development of heparin-coated magnetic nanoparticles for targeted drug delivery applications. J Appl Phys 105(7):07B308. doi: 10.1063/1.306801810.1063/1.3068018 ↗
22. Ki-Chul K, Eung-Kwon K, Jae-One L, Young-Sung K (2006) Characterization of magnetic nanoparticles synthesized by sonomechanical method. In: Nanotechnology Materials and Devices Conference, 2006. NMDC 2006. IEEE, vol 1, pp 600–601. doi: 10.1109/NMDC.2006.438892210.1109/NMDC.2006.4388922 ↗
23. Lee IS, Lee N, Park J, Kim BH, Yi YW, Kim T, Kim TK, Lee IH, Paik SR, Hyeon T (2006) Ni/NiO core/shell nanoparticles for selective binding and magnetic separation of histidine-tagged proteins. J Am Chem Soc 128(33):10,658–10,659. doi: 10.1021/ja063177n10.1021/ja063177n ↗
24. Lee S, Ahn C, Lee J, Lee J, Chang J (2012) Rapid and selective separation for mixed proteins with thiol functionalized magnetic nanoparticles. Nanoscale Res Lett 7:279. doi: 10.1186/1556-276X-7-27910.1186/1556-276X-7-279 ↗
25. Low D, O’Leary R, Pujar NS (2007) Future of antibody purification. J Chromatogr B 848(1):48–63. doi: 10.1016/j.jchromb.2006.10.03310.1016/j.jchromb.2006.10.033 ↗
26. McIntyre NS, Zetaruk DG (1977) X-ray photoelectron spectroscopic studies of iron oxides. Anal Chem 49(11):1521–1529. doi: 10.1002/sia.198410.1021/ac50019a016 ↗
27. Minati L, Micheli V, Rossi B, Migliaresi C, Dalbosco L, Bao G, Hou S, Speranza G (2011) Application of factor analysis to XPS valence band of superparamagnetic iron oxide nanoparticles. Appl Surf Sci 257(24):10,863–10,868. doi: 10.1016/j.apsusc.2011.07.12310.1016/j.apsusc.2011.07.123 ↗
28. Mornet S, Vasseur S, Grasset F, Duguet E (2004) Magnetic nanoparticle design for medical diagnosis and therapy. J Mater Chem 14(14):2161–2175. doi: 10.1039/b402025a10.1039/b402025a ↗
29. Palecek E, Fojta M (2007) Magnetic beads as versatile tools for electrochemical DNA and protein biosensing. Talanta 74(3):276–290. doi: 10.1016/j.talanta.2007.08.02010.1016/j.talanta.2007.08.020 ↗
30. Roque A, Cecilia A, Lowe CR, Taipa MA (2004) Antibodies and genetically engineered related molecules: production and purification. Biotechnol Prog 20(3):639–654. doi: 10.1021/bp030070k10.1021/bp030070k ↗
31. Schneider CA, Rasband WS, Eliceiri KW (2012) NIH image to ImageJ: 25 years of image analysis. Nat Methods 9(7):671–675. doi: 10.1038/nmeth.208910.1038/nmeth.2089 ↗
32. Shieh DB, Su CH, Chang FY, Wu YN, Su WC, Hwu J, Chen JH, Yeh CS (2006) Aqueous nickel-nitrilotriacetate modified Fe3O4–NH 3 + nanoparticles for protein purification and cell targeting. Nanotechnology 17(16):4174–4182. doi: 10.1088/0957-4484/17/16/03010.1088/0957-4484/17/16/030 ↗
33. Sopaci S, Simsek I, Tural B, Volkan M, Demir A (2009) Carboligation reactions with benzaldehyde lyase immobilized on superparamagnetic solid support. Org Biomol Chem 7(8):1658–1664. doi: 10.1039/b819722a10.1039/b819722a ↗
34. Suzer S, Baer DR, Engelhard MH (2010) Analysis of Fe nanoparticles using XPS measurements under d.c. or pulsed-voltage bias. Surf Interface Anal 42(6–7):859–862. doi: 10.1002/sia.326010.1002/sia.3260 ↗
35. Xu C, Xu K, Gu H, Zheng R, Liu H, Zhang X, Guo Z, Xu B (2004) Dopamine as a robust anchor to immobilize functional molecules on the iron oxide shell of magnetic nanoparticles. J Am Chem Soc 126(32):9938–9939. doi: 10.1021/ja046480210.1021/ja0464802 ↗